Measuring the composition of the tumor microenvironment with transcriptome analysis: past, present and future

被引:5
|
作者
Zhang, Han [1 ]
Lu, Xinghua [1 ,2 ]
Lu, Binfeng [3 ]
Gullo, Giuseppe [4 ]
Chen, Lujia [1 ]
机构
[1] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15206 USA
[2] UPMC Hillman Canc Ctr, Pittsburgh, PA 15232 USA
[3] Hackensack Meridian Hlth, Ctr Discovery & Innovat, Nutley, NJ 07110 USA
[4] Univ Palermo, Villa Sofia Cervello Hosp, Dept Obstet & Gynecol, I-90146 Palermo, Italy
关键词
bulk-RNAseq; cell-cell network; deconvolution; immune phenotype; immunotherapy; scRNAseq; spatial transcriptome; TME subtype; tumor microenvironment; OX40; AGONIST; CELL-DEATH; IMMUNOTHERAPY; RADIOTHERAPY; COMBINATION; AUTOPHAGY; IMMUNITY;
D O I
10.2217/fon-2023-0658
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interactions between tumor cells and immune cells in the tumor microenvironment (TME) play a vital role the mechanisms of immune evasion, by which cancer cells escape immune elimination. Thus, the characterization and quantification of different components in the TME is a hot topic in molecular biology and drug discovery. Since the development of transcriptome sequencing in bulk tissue, single cells and spatial dimensions, there are increasing methods emerging to deconvolute and subtype the TME. This review discusses and compares such computational strategies and downstream subtyping analyses. Integrative analyses of the transcriptome with other data, such as epigenetics and T-cell receptor sequencing, are needed to obtain comprehensive knowledge of the dynamic TME.
引用
收藏
页码:1207 / 1220
页数:14
相关论文
共 50 条
  • [21] GENESIS SOLAR COMPOSITION: PAST, PRESENT, AND FUTURE.
    Burnett, D. S.
    METEORITICS & PLANETARY SCIENCE, 2012, 47 : A89 - A89
  • [22] Tumor immunology CRISPR screening: present, past, and future
    Dong, Matthew B.
    Tang, Kaiyuan
    Zhou, Xiaoyu
    Zhou, Jingjia J.
    Chen, Sidi
    TRENDS IN CANCER, 2022, 8 (03) : 210 - 225
  • [23] Imaging assessment of tumor response: past, present and future
    Afaq, Asim
    Akin, Oguz
    FUTURE ONCOLOGY, 2011, 7 (05) : 669 - 677
  • [24] INTRAOPERATIVE RADIOIMMUNODETECTION OF OCCULT TUMOR - PAST, PRESENT AND FUTURE
    MARTIN, EW
    PATHOLOGIE BIOLOGIE, 1990, 38 (08): : 817 - 818
  • [25] Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
    Komarnicki, Pawel
    Musialkiewicz, Jan
    Stanska, Alicja
    Maciejewski, Adam
    Gut, Pawel
    Mastorakos, George
    Ruchala, Marek
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [26] TUMOR-MARKERS IN ONCOLOGY - PAST, PRESENT AND FUTURE
    MAGDELENAT, H
    JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 150 (1-2) : 133 - 143
  • [27] Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
    McGranahan, Nicholas
    Swanton, Charles
    CELL, 2017, 168 (04) : 613 - 628
  • [29] Living in the Past, Present, and Future: Measuring Temporal Orientation With Language
    Park, Gregory
    Schwartz, H. Andrew
    Sap, Maarten
    Kern, Margaret L.
    Weingarten, Evan
    Eichstaedt, Johannes C.
    Berger, Jonah
    Stillwell, David J.
    Kosinski, Michal
    Ungar, Lyle H.
    Seligman, Martin E. P.
    JOURNAL OF PERSONALITY, 2017, 85 (02) : 270 - 280
  • [30] Past, present and future of blood pressure measuring instruments and their calibration
    Kumar, Rahul
    Dubey, P. K.
    Zafer, Afaqul
    Kumar, Ashok
    Yadav, Sanjay
    MEASUREMENT, 2021, 172